Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro.
about
PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas)Melanoma. Shall we move away from the sun and focus more on embryogenesis, body weight and longevity?Informatic and genomic analysis of melanocyte cDNA libraries as a resource for the study of melanocyte development and function.Networks and pathways in pigmentation, health, and disease.NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.Molecular analysis of common polymorphisms within the human Tyrosinase locus and genetic association with pigmentation traitsSox proteins in melanocyte development and melanoma.An iterative genetic and dynamical modelling approach identifies novel features of the gene regulatory network underlying melanocyte development.Transcriptome profiling of natural dichromatism in the annual fishes Nothobranchius furzeri and Nothobranchius kadleciPAX3 and SOX10 activate MET receptor expression in melanoma.Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanomaSOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentationEpigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo.Gene expression divergence and nucleotide differentiation between males of different color morphs and mating strategies in the ruffPigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and diseasePAX3 across the spectrum: from melanoblast to melanoma.Cutaneous short-interfering RNA therapy.Developmental pathways activated in melanocytes and melanoma.Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma.Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathwayThe transcription factor Sox5 modulates Sox10 function during melanocyte development.Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf.MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.Genetic variation in IRF4 expression modulates growth characteristics, tyrosinase expression and interferon-gamma response in melanocytic cells.DCT protects human melanocytic cells from UVR and ROS damage and increases cell viability.Pax3 transcripts in melanoblast development.Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?
P2860
Q21090021-6B55F393-7FB0-4464-87D8-1F9EF9B33145Q26853315-C246398E-90A3-490E-9B9E-0C1DC7EBDD13Q33285294-F60B8298-0988-4C11-BCF9-6FDD1B7DE409Q33584524-24BCC4F4-53BB-40A0-905B-A3246C347DA7Q33809465-FA267361-0EEB-4990-86E7-02996A8289ADQ33991072-FA6CBCC3-7801-49CE-B9D3-4383FB0020B7Q34005547-CD2BDE77-113D-4023-BC7B-A672A22A1AD3Q34016272-D36DE7E3-348F-4B61-93EB-C2ABE4DB732FQ34207977-ACDD0D85-D7C2-4216-A598-2876FF5A5125Q34302054-21080704-F55F-43E3-A731-1AB6E68944F3Q35023613-BBB7CF76-71A0-4892-8F14-3936283127CFQ35229597-04223531-6C0C-4030-AFB7-C2C7280ACE84Q35956740-3AB509E5-1F36-41E4-9D59-E0F8C80F10C7Q36266756-BF08F212-9D88-4D3D-8488-8A2015559D72Q36382250-8939A1AA-23AC-4314-8804-215AE3F1A3A9Q37317139-9CED1F7F-4791-42D4-8EB7-D173A4E4F55FQ37463808-8413C7A2-6DEA-4980-B476-C3746138A185Q37639312-896E4938-FFF0-4DA5-B473-E6B29B1F63A8Q38238576-D7165CD2-9CC4-452C-8DC0-91FBBFC88042Q38394400-3D7DE24B-866F-4F14-A3CC-C37258058C9AQ39558296-BEFF414A-2F93-476B-A985-38F1765B1DD3Q39584685-12E34382-F7D8-4444-9490-0DF4AF48CD27Q39950581-C3AA05FF-3BFE-41AC-B284-2F642638D303Q40223081-863953EA-1880-4783-A873-9D12FB572778Q41536617-9331B189-68A1-4211-969D-A8F17D2965BAQ42513019-230FE051-6891-4933-ABA7-947FDAC892EAQ46821427-51B2FA52-AEF0-41A3-8508-866232973F78Q46826614-16FCE7DA-984B-4F65-A4A9-37C2D67104C9Q54952133-DDA76BDC-719A-4CDE-A9D1-783757588D26
P2860
Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro.
@en
type
label
Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro.
@en
prefLabel
Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro.
@en
P50
P1476
Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro
@en
P2093
J Helen Leonard
P304
P356
10.1016/J.YEXCR.2005.04.019
P407
P577
2005-08-01T00:00:00Z